ORIGINAL RESEARCH
Accepted on 11 Jul 2025
Single-Agent Rituximab and Ultra-Low-Dose Adaptive Radiotherapy for the Treatment of Indolent B-cell Non-Hodgkin Lymphomas (iNHL)
doi 10.3389/fonc.2025.1617087
- 479 views
1,817
Total downloads
9,292
Total views and downloads
ORIGINAL RESEARCH
Accepted on 11 Jul 2025
PERSPECTIVE
Published on 01 Apr 2025
REVIEW
Published on 31 Mar 2025
REVIEW
Published on 21 Mar 2025
ORIGINAL RESEARCH
Published on 20 Mar 2025
MINI REVIEW
Published on 06 Feb 2025
ORIGINAL RESEARCH
Published on 11 Sep 2024